Resultados de procura - James Sun

Limitar resultados
  1. 1
    Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

    Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy por James Sun, Jonathan S. Zager, Zeynep Eroglu

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment

    The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment por James Sun, Kameko M Karasaki, Jeffrey M. Farma

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    The cardiac output from blood pressure algorithms trial*

    The cardiac output from blood pressure algorithms trial* por James Sun, Andrew Reisner, M. A. Saeed, Thomas Heldt, Roger G. Mark

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis

    Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis por Hongru Li, Lei Deng, Harrison X. Bai, James Sun, Yangbin Cao, Yongguang Tao, Lisa J. States, Michael D. Farwell, Paul J. Zhang, Bo Xiao, Li Yang

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?

    Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition? por Charlotte Pawlyn, Andrea Loehr, Cody Ashby, Ruslana G. Tytarenko, Shayu Deshpande, James Sun, Kyle Fedorchak, Tariq I. Mughal, Faith E. Davies, Brian A. Walker, Gareth J. Morgan

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal

    A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal por James Sun, Yuting He, Eric M. Sanford, Meagan Montesion, Garrett M. Frampton, Stéphane Vignot, Jean‐Charles Soria, Jeffrey S. Ross, Vincent A. Miller, Phil Stephens, Doron Lipson, Roman Yelensky

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Biological and clinical evidence for somatic mutations in <i>BRCA1</i> and <i>BRCA2</i> as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting

    Biological and clinical evidence for somatic mutations in <i>BRCA1</i> and <i>BRCA2</i> as predictive markers for olaparib response in high-grade serous ovarian cancers in the main... por Brian Dougherty, Zhongwu Lai, Darren Hodgson, Maria Orr, Matthew Hawryluk, James Sun, Roman Yelensky, Stuart Spencer, Jane Robertson, Tony W. Ho, Anitra Fielding, Jonathan A. Ledermann, J. Carl Barrett

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Genomic Profiling of Small-Bowel Adenocarcinoma

    Genomic Profiling of Small-Bowel Adenocarcinoma por Alexa B. Schrock, Craig Devoe, Robert R. McWilliams, James Sun, Thomas Aparicio, Philip J. Stephens, Jeffrey S. Ross, Richard H. Wilson, Vincent A. Miller, Siraj M. Ali, Michael J. Overman

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries

    Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries por James Sun, Linda Zhou, Daniel J. Emerson, Sai Aung Phyo, Katelyn R. Titus, Wanfeng Gong, Thomas G. Gilgenast, Jonathan A. Beagan, Beverly L. Davidson, Flora Tassone, Jennifer E. Phillips‐Cremins

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer

    Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer por Andrew Rankin, Samuel J. Klempner, Rachel Erlich, James Sun, Axel Grothey, Marwan Fakih, Thomas J. George, Jeeyun Lee, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Alexa B. Schrock

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Relapsed Classic E-Cadherin (<i>CDH1</i>)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of<i>HER2</i>(<i>ERBB2</i>) Gene Mutations

    Relapsed Classic E-Cadherin (<i>CDH1</i>)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of<i>HER2</i>(<i>ERBB2</i>) Gene Mutations por Jeffrey S. Ross, Kai Wang, Christine E. Sheehan, Ann Boguniewicz, Geoff Otto, Sean R. Downing, James Sun, Jie He, John A. Curran, Siraj M. Ali, Roman Yelensky, Doron Lipson, Gary A. Palmer, Vincent A. Miller, Philip J. Stephens

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i>

    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i> por Jeffrey S. Ross, Marwan Fakih, Siraj M. Ali, Julia A. Elvin, Alexa B. Schrock, James Suh, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, James Sun, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition

    Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition por David Fabrizio, Thomas J. George, Richard F. Dunne, Garrett M. Frampton, James Sun, Kyle Gowen, Mark Kennedy, Joel Greenbowe, Alexa B. Schrock, Aram F. Hezel, Jeffrey S. Ross, P. J. Stephens, Siraj M. Ali, Vincent A. Miller, Marwan Fakih, Samuel J. Klempner

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Oncogenic <i>ALK</i> Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target

    Oncogenic <i>ALK</i> Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target por Evgeny Yakirevich, Murray B. Resnick, Shamlal Mangray, Michael B. Wheeler, Cynthia L. Jackson, Kara A. Lombardo, Jeeyun Lee, Kyoung‐Mee Kim, Anthony J. Gill, Kai Wang, Kyle Gowen, James Sun, Vincent A. Miller, Philip J. Stephens, Siraj M. Ali, Jeffrey S. Ross, Howard Safran

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples

    A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient S... por Sally E. Trabucco, Kyle Gowen, Sophia L. Maund, Eric M. Sanford, David Fabrizio, Michael J. Hall, Evgeny Yakirevich, Jeffrey P. Gregg, Phil Stephens, Garrett M. Frampton, Priti S. Hegde, Vincent A. Miller, Jeffrey S. Ross, Ryan J. Hartmaier, Shih-Min A. Huang, James Sun

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    <sup>Non-V600</sup><i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

    <sup>Non-V600</sup><i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer por Jeremy Jones, Lindsay A. Renfro, Humaid O. Al‐Shamsi, Alexa B. Schrock, Andrew Rankin, Ben Y. Zhang, Pashtoon Murtaza Kasi, Jesse S. Voss, Alexis D. Leal, James Sun, Jeffrey S. Ross, Siraj M. Ali, Joleen M. Hubbard, Benjamin R. Kipp, Robert R. McWilliams, Scott Kopetz, Robert A. Wolff, Axel Grothey

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma

    Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma por Andreas Heilmann, Vivek Subbiah, Kai Wang, James Sun, Julia A. Elvin, Juliann Chmielecki, Steven I. Sherman, Ravi Murthy, Naifa L. Busaidy, Ishwaria M. Subbiah, Roman Yelensky, Chaitali Nangia, Jo-Anne Vergilio, Saad A. Khan, Rachel Erlich, Doron Lipson, Jeffrey S. Ross, Vincent A. Miller, Manisha H. Shah, Siraj M. Ali, Philip J. Stephens

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies

    Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies por Matthew P. Goetz, James Sun, Vera J. Suman, Grace O. Silva, Charles M. Perou, Yusuke Nakamura, Nancy J. Cox, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross, David Chen, Stephanie L. Safgren, Mary J. Kuffel, Matthew M. Ames, Krishna R. Kalari, Henry Gómez, Ana M. González-Angulo, Octavio Burgués, Hiltrud Brauch, James N. Ingle, Mark J. Ratain, Roman Yelensky

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

    Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden por Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis

    Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis por John T. Miura, Hidde M. Kroon, Georgia M. Beasley, Dean Mullen, Norma E. Farrow, Paul J. Mosca, Michael Lowe, Clara R. Farley, Youngchul Kim, Syeda Mahrukh Hussnain Naqvi, Aishwarya Potdar, Hala Daou, James Sun, Jeffrey M. Farma, Michael A. Henderson, David Speakman, Jonathan W. Serpell, Keith A. Delman, B. Mark Smithers, Brendon J. Coventry, Douglas S. Tyler, John F. Thompson, Jonathan S. Zager

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: